Related Experiment Videos
Primary gastrointestinal sarcomas: analysis of prognostic variables
K C Conlon1, E S Casper, M F Brennan
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
Annals of Surgical Oncology
|January 1, 1995
Summary
Complete surgical resection is optimal for gastrointestinal sarcomas, but high-grade tumors require additional therapies. Prognosis remains poor, emphasizing the need for investigational adjuvant treatments for these aggressive cancers.
Area of Science:
- Oncology
- Surgical Pathology
- Gastroenterology
Background:
- Primary gastrointestinal sarcomas are rare malignancies with unclear prognostic factors.
- Understanding clinicopathological determinants is crucial for improving patient outcomes.
- This study analyzes institutional experience to correlate tumor characteristics with survival.
Purpose of the Study:
- To correlate clinical presentation, pathological assessment, and treatment with survival outcomes in primary gastrointestinal sarcomas.
- To identify significant prognostic factors influencing patient survival.
- To evaluate the efficacy of surgical resection and potential need for adjuvant therapies.
Main Methods:
- Retrospective review of adult patients (over 16 years) diagnosed with primary gastrointestinal sarcoma between July 1982 and December 1991.
- Analysis included patient demographics, tumor site, histological type, grade, surgical treatment, and follow-up data.
- Statistical methods were used to identify prognostic factors for overall survival.
Main Results:
- Thirty-eight patients were identified, with leiomyosarcoma being the predominant type (n=35).
- High-grade tumors (68%) and incomplete surgical resection were associated with significantly poorer survival.
- Weight loss and pain at presentation were adverse prognostic factors; 5-year survival was 28%.
Conclusions:
- Primary gastrointestinal sarcomas have a poor prognosis, with complete surgical excision being the primary treatment.
- Surgery alone is insufficient for high-grade tumors, necessitating further investigation.
- Patients with high-grade gastrointestinal sarcomas should be considered for investigational adjuvant therapies.